ATAC - Endometrial Sub-Protocol
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Anastrozole (Arimidex)|DRUG: Tamoxifen (Nolvadex)|DRUG: Nolvadex placebo|DRUG: Arimidex placebo
Sponsor: AstraZeneca